The upfront combination chemohormonal therapy produced a statistically and clinically significant improvement in overall survival compared with ADT alone (52.7 versus 42.3 months with p value 0.0006, Hazard ratio 0.63 (0.48, 0.82)) [ 8 ].
Source: wiktionary